Annual FCF
-$119.33 M
-$311.73 M-162.02%
31 December 2023
Summary:
Foghorn Therapeutics annual free cash flow is currently -$119.33 million, with the most recent change of -$311.73 million (-162.02%) on 31 December 2023. During the last 3 years, it has fallen by -$71.86 million (-151.39%). FHTX annual FCF is now -162.02% below its all-time high of $192.40 million, reached on 31 December 2022.FHTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$21.31 M
+$4.24 M+16.59%
30 September 2024
Summary:
Foghorn Therapeutics quarterly free cash flow is currently -$21.31 million, with the most recent change of +$4.24 million (+16.59%) on 30 September 2024. Over the past year, it has increased by +$5.98 million (+21.90%). FHTX quarterly FCF is now -107.86% below its all-time high of $271.29 million, reached on 31 March 2022.FHTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$103.89 M
+$5.98 M+5.44%
30 September 2024
Summary:
Foghorn Therapeutics TTM free cash flow is currently -$103.89 million, with the most recent change of +$5.98 million (+5.44%) on 30 September 2024. Over the past year, it has increased by +$17.05 million (+14.10%). FHTX TTM FCF is now -142.81% below its all-time high of $242.66 million, reached on 31 March 2022.FHTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -162.0% | +21.9% | +14.1% |
| 3 y3 years | -151.4% | -2.8% | -24.4% |
| 5 y5 years | -393.3% | - | - |
FHTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -162.0% | at low | -107.9% | +34.7% | -142.8% | +14.1% |
| 5 y | 5 years | -162.0% | at low | -107.9% | +34.7% | -142.8% | +14.1% |
| alltime | all time | -162.0% | at low | -107.9% | +34.7% | -142.8% | +14.1% |
Foghorn Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.31 M(-16.6%) | -$103.89 M(-5.4%) |
| June 2024 | - | -$25.55 M(-13.2%) | -$109.87 M(-6.1%) |
| Mar 2024 | - | -$29.45 M(+6.8%) | -$116.96 M(-2.0%) |
| Dec 2023 | -$119.33 M(-162.0%) | -$27.58 M(+1.0%) | -$119.33 M(-1.3%) |
| Sept 2023 | - | -$27.29 M(-16.4%) | -$120.94 M(+6.1%) |
| June 2023 | - | -$32.64 M(+2.6%) | -$113.97 M(+3.0%) |
| Mar 2023 | - | -$31.82 M(+9.0%) | -$110.70 M(-157.5%) |
| Dec 2022 | $192.40 M | -$29.19 M(+43.7%) | $192.40 M(-17.6%) |
| Sept 2022 | - | -$20.32 M(-30.8%) | $233.40 M(+0.2%) |
| June 2022 | - | -$29.38 M(-110.8%) | $232.98 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $271.29 M(+2198.7%) | $242.66 M(-553.0%) |
| Dec 2021 | -$53.56 M(+12.8%) | $11.80 M(-156.9%) | -$53.56 M(-35.9%) |
| Sept 2021 | - | -$20.73 M(+5.3%) | -$83.51 M(+27.5%) |
| June 2021 | - | -$19.69 M(-21.0%) | -$65.48 M(+8.0%) |
| Mar 2021 | - | -$24.94 M(+37.5%) | -$60.63 M(+27.7%) |
| Dec 2020 | -$47.47 M(+0.4%) | -$18.14 M(+572.2%) | -$47.47 M(+61.9%) |
| Sept 2020 | - | -$2.70 M(-81.8%) | -$29.32 M(+10.1%) |
| June 2020 | - | -$14.84 M(+26.0%) | -$26.63 M(+126.0%) |
| Mar 2020 | - | -$11.78 M | -$11.78 M |
| Dec 2019 | -$47.30 M(+95.6%) | - | - |
| Dec 2018 | -$24.19 M | - | - |
FAQ
- What is Foghorn Therapeutics annual free cash flow?
- What is the all time high annual FCF for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual FCF year-on-year change?
- What is Foghorn Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly FCF year-on-year change?
- What is Foghorn Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Foghorn Therapeutics?
- What is Foghorn Therapeutics TTM FCF year-on-year change?
What is Foghorn Therapeutics annual free cash flow?
The current annual FCF of FHTX is -$119.33 M
What is the all time high annual FCF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual free cash flow is $192.40 M
What is Foghorn Therapeutics annual FCF year-on-year change?
Over the past year, FHTX annual free cash flow has changed by -$311.73 M (-162.02%)
What is Foghorn Therapeutics quarterly free cash flow?
The current quarterly FCF of FHTX is -$21.31 M
What is the all time high quarterly FCF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly free cash flow is $271.29 M
What is Foghorn Therapeutics quarterly FCF year-on-year change?
Over the past year, FHTX quarterly free cash flow has changed by +$5.98 M (+21.90%)
What is Foghorn Therapeutics TTM free cash flow?
The current TTM FCF of FHTX is -$103.89 M
What is the all time high TTM FCF for Foghorn Therapeutics?
Foghorn Therapeutics all-time high TTM free cash flow is $242.66 M
What is Foghorn Therapeutics TTM FCF year-on-year change?
Over the past year, FHTX TTM free cash flow has changed by +$17.05 M (+14.10%)